Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/9734938

Lancet 1998 Mar 28 351 9107 929-33

Download in:

View as

General Info

PMID
9734938